Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
								
																		
									
																											
																		
									
																											
																		
									
										
											Monoisotopic mass 
										
										
											411.044439726										
									 
																											
									
																		
									
										
											InChI 
										
										
											InChI=1S/C20H14ClN3O3S/c21-14-7-3-2-6-13(14)15-11-28-20(22-15)23-19(27)17-9-12-5-1-4-8-16(12)24(17)10-18(25)26/h1-9,11H,10H2,(H,25,26)(H,22,23,27)										
									 
																		
																		
										
											InChI Key 
										
										
											InChIKey=ILNRQFBVVQUOLP-UHFFFAOYSA-N										
									 
																											
																		
										
											IUPAC Name 
										
										
											2-(2-{[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl}-1H-indol-1-yl)acetic acid										
									 
																											
																		
										
											Traditional IUPAC Name 
										
										
											(2-{[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl}indol-1-yl)acetic acid										
									 
																											
									
																		
										
											SMILES 
										
										
											OC(=O)CN1C(=CC2=CC=CC=C12)C(=O)NC1=NC(=CS1)C1=CC=CC=C1Cl										
									 
																		
																		
									
																		
																		
																		
																											
																		
																											
																		
																											
																		
										
											pKa (strongest acidic) 
										
										
											4.19										
									 
																											
																		
										
											pKa (Strongest Basic) 
										
										
											-1.2										
									 
																											
																		
																											
																		
										
											Refractivity 
										
										
											107.79 m3·mol-1
										
									 
																			  
		  
																		
																											
																		
																		
									
																		
																		
																		
																		
																		
																		
																		
																		
											  
		  
								 
							 	
														
															
								 Dược Lực Học : 
								
									Lintitript SR 27897 is a selective cholecystokinin type A (CCK-A) receptor antagonist. In February 2000, Sanofi announced that it was halting development of the drug for appetite disorders, and in September 2002, Sanofi announced that it had stopped investigation all together.									
							
														
															
								 Cơ Chế Tác Dụng : 
								
									Lintitript is a new, highly specific and potent CCK-A receptor antagonist.								
								
									Cholecystokinin (CCK) modulates feeding and dopamine-induced behavior in the central and peripheral nervous system. Lintitript antagonizes the effect of cholecystokinin by binding to the cholecystokinin type A (CCK-A) receptor. This action presumably alters feeding habits, however the exact mechanism of action is not known.								
							
														
														
														
							
																					
								 Chỉ Định : 
								
									For the treatment of pancreatic cancer and appetite disorders.